GlassScriptPhysician profile
Jagan Akella
NPI 1609917665
$11,303.51
in general payments reported to CMS, 2019-2025
39 companies · $2,803 in 2025
The $2,803 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $997 · 2020: $1,159 · 2021: $1,553 · 2022: $1,515 · 2023: $1,619 · 2024: $1,657 · 2025: $2,803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,079.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,327.28 | 2019-2025 | Tacticath Ablation Catheter, Sensor Enabled, Ensite Precision, Amplatzer Amulet |
| Boston Scientific Corporation | $1,221.19 | 2019-2025 | General - Brady, Lux-Dx Insertable Cardiac Monitor, Accolade Sr |
| Janssen Pharmaceuticals, INC | $1,113.95 | 2019-2024 | Xarelto |
| Biotronik INC. | $815.78 | 2020-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Renamic Neo |
| Pfizer INC. | $732.87 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $514.97 | 2019-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $510.85 | 2021-2025 | Ffrangio, Mycarelink, Reveal Linq |
| Novartis Pharmaceuticals Corporation | $445.65 | 2019-2025 | |
| Reflow Medical INC | $436.61 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $397.55 | 2022-2025 | Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $393.49 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $373.13 | 2019-2023 | Farxiga |
| Biosense Webster, INC. | $347.03 | 2022-2025 | Carto 3, Nuvision Ice Catheter, Na |
| Sanofi-Aventis U.S. LLC | $256.79 | 2019-2024 | |
| Cvrx, INC. | $217.72 | 2022-2025 | Barostim Neo System |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $214.37 | 2019-2025 | Lifevest |
| Cardiva Medical, INC. | $193.28 | 2024-2025 | Cardiva Vascade 6/7f Vcs, Esophageal Cooling Device, Cardiva Vascade Mvp Vvcs 6-12f |
| Stryker Corporation | $180.58 | 2025 | Artix Mt, Flowtriever |
| Astellas Pharma US INC | $175.12 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $164.03 | 2022-2023 | Assure Wcd |
| Inari Medical, INC. | $160.55 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $130.13 | 2020 | |
| Amgen INC. | $129.28 | 2019-2025 | Repatha |
| Portola Pharmaceuticals, LLC | $106.67 | 2020 | |
| Lundbeck LLC | $104.69 | 2019-2021 | |
| Elutia, INC. | $96.61 | 2019-2025 | Ecm Patch,Pouch |
| Merck Sharp & Dohme LLC | $93.97 | 2021-2023 | Verquvo |
| Bardy Diagnostics, INC. | $90.00 | 2020 | |
| Jubilant Draximage, INC. | $65.13 | 2025 | Technetium Tc 99m Sestamibi |
| Cardinal Health 200 LLC | $62.10 | 2019 | |
| Esperion Therapeutics, INC. | $48.09 | 2021 | |
| W. L. Gore & Associates, INC. | $37.98 | 2023 | C3 Delivery System |
| Terumo Medical Corporation | $34.55 | 2023-2024 | Angio-Seal, Tr Band |
| Impulse Dynamics (USA) INC. | $26.40 | 2023 | Optimizer |
| Atricure, INC. | $19.81 | 2019 | |
| Acutus Medical, INC. | $18.97 | 2023 | |
| Glaxosmithkline, LLC. | $18.09 | 2025 | Arexvy, Shingrix |
| Ge Healthcare | $15.86 | 2022 | |
| G Medical Diagnostic Services, INC. | $12.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jagan Akella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.